DRDO invites EoI to transfer technology of 2-DG drug for bulk production


303104



2-DG was developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in collaboration with Dr Reddy’s Laboratories.

Defence Minister Rajnath Singh hands over the 2G drug to Health Minister Dr Harsh Vardhan (Twitter/@rajnathsingh)

The Defence Research and Development Organisation (DRDO), which developed 2-Deoxy-D-Glucose (2-DG), a drug used for treatment of COVID-19 patients, has called for Expression of Interest (EoI) to transfer the technology to Indian pharmaceutical industries for production.

Clinical trial results have shown that this molecule helps in faster recovery of hospitalised patients and reduces supplemental oxygen dependence.



Read More at India Express


Like it? Share with your friends!

303104

What's Your Reaction?

hate hate
4566
hate
confused confused
13698
confused
fail fail
9132
fail
fun fun
7610
fun
geeky geeky
6088
geeky
love love
1522
love
lol lol
3044
lol
omg omg
13698
omg
win win
9132
win
PTI

0 Comments

Your email address will not be published. Required fields are marked *

Choose A Format
Personality quiz
Series of questions that intends to reveal something about the personality
Trivia quiz
Series of questions with right and wrong answers that intends to check knowledge
Poll
Voting to make decisions or determine opinions
Story
Formatted Text with Embeds and Visuals
List
The Classic Internet Listicles
Countdown
The Classic Internet Countdowns
Open List
Submit your own item and vote up for the best submission
Ranked List
Upvote or downvote to decide the best list item
Meme
Upload your own images to make custom memes
Video
Youtube, Vimeo or Vine Embeds
Audio
Soundcloud or Mixcloud Embeds
Image
Photo or GIF
Gif
GIF format